FDA Approves Colchicine for Acute Gout, Mediterranean Fever
Thu, 30 Jul 2009 17:58:00 EST
The U.S. Food and Drug Administration has approved Colcrys to treat acute flairs in patients with gout, a recurrent and painful form of arthritis, and patients with familial Mediterranean fever (FMF), an inherited inflammatory disorder. The medication’s active ingredient is colchicine, a complex compound derived from the dried seeds of a plant known as the autumn crocus or meadow saffron (Colchicum autumnale).
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm174620.htm
